Compositions comprising sphingosine 1 phosphate (S1P) receptor modulators

Details for Australian Patent Application No. 2012216630 (hide)

Owner Novartis AG

Inventors Ambuhl, Michael; Ruegger, Colleen

Agent Davies Collison Cave

Pub. Number AU-A-2012216630

Parent 2008310846

Filing date 4 September 2012

Wipo publication date 20 September 2012

International Classifications

A61K 47/00 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

Event Publications

20 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216630

20 September 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216631-Testing of defibrillator electrodes

2012216628-Novel Formulations which Stabilize and Inhibit Precipitation of Immunogenic Compositions